(Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of using the same coronavirus strain for the initial COVID-19 vaccine doses and the boosters, to simplify the vaccination regimen in the United States.
(Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of using the same coronavirus strain for the initial COVID-19 vaccine doses and the boosters, to simplify the vaccination regimen in the United States.
(Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: